Abstract
Innovations in regenerative medicine and cell therapy have made possible multiple breakings in the laws and paradigms that determined the beginnings of 20th century biology. The destabilisation of categories and heteronormative dichotomies that demarcated this science made possible the irruption of studies that separated genetic research from sex. Even so, the current implementation of these techno-scientific developments produce other types of exclusion mechanisms we will analyse from a bio-economic point of view: from the reinforcement of the conditions of vulnerability of women donors, to the support of therapeutic promises that semiotically disconnect the contexts of uncertainty of these technologies or the implementation of a performative understanding of health in terms of individual consumption.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clepsydra. Revista de Estudios de Género y Teoría Feminista
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
